Skip to main content
. 2014 Mar 7;5(1):169–181. doi: 10.1007/s13300-014-0059-x

Table 2.

Change in HbA1c (%) in subpopulations of patients taking metformin 250 mg bid or 500 mg bid (full analysis set)

Treatment n Baseline mean (SE) Mean change (SE) 95% CI (P value)
Vildagliptin + metformin 250 mg bid 34 7.9 (0.13) −1.1 (0.09) −1.24, −0.88 (P < 0.001)
Vildagliptin + metformin 500 mg bid 34 8.1 (0.15) −1.1 (0.09) −1.24, −0.88 (P < 0.001)

CI confidence interval, HbA 1c glycosylated hemoglobin, SE standard error